Sensus Healthcare, Inc. has launched Sensus Laser Systems, a unique multi-platform line of high-quality, cost-effective dermatological lasers to complement its existing superficial radiation therapy (SRT) system, which is used for non-invasive treatment of non-melanoma skin cancers and keloids. The company's new platform includes applications for hair and tattoo removal, acne lesion correction, skin rejuvenation and pigmentation/large pore treatment.
"With the launch of Sensus Laser Systems, we are uniquely positioned to offer such a wide range of aesthetic and clinical solutions to patients not only to treat skin cancer but also to help people look and feel their best from head to toe," said Kal Fishman, Sensus Healthcare CTO. "Sensus Laser Systems marks the Company's entrance into the aesthetic laser market and offers outstanding value for providers, ultimately enabling them to offer more solutions—from cutaneous oncology to keloids to aesthetics—to patients."
Sensus' three new laser systems include:
- Fractional CO2 – for surgical applications that require ablation vaporization, excision, incision and coagulation of soft tissue
- IPL – for hair removal, skin rejuvenation, vascular and pigmented lesions
- Q-Switched ND:YAG – for tattoo removal, pigmented lesion treatment, age spots, freckles and sun spots
"Now that we've opened our Tel Aviv R&D office to meet the demand from our current customers, we're making inroads in accessing and building relationships with the most innovative minds in dermatology and aesthetics," added Joe Sardano, Sensus Healthcare CEO. "As we have other indications that are on the horizon, our mission is not only to bring state-of-the-art lasers to patients all over the world but also to focus on developing the next generation of aesthetic dermatology products overall. 2018 will be the year to watch the Company as we expand into aesthetics and beyond."